secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0001683168-24-003598
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio Pharmaceuticals enters purchase agreement with Triton Funds for up to $621k at $0.72 per share
--------------------------------------------------------------------------------

- Up to 862,500 shares at $0.72/share, representing ~18.8% of outstanding shares.
- Gross proceeds up to $621,000; agreement expires Nov 17, 2024 or upon full sale.
- Triton has covenanted not to engage in any short selling of PHIO common stock.
- Offered under existing shelf registration; prospectus supplement to be filed.
- Company may request purchases in one or more transactions based on market conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316824003598/0001683168-24-003598-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316824003598/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-003598

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer